Languages Available
English - 中文 - 日本語
 
C

PT. Darya-Varia Laboratoria Tbk [DVLA]   Rp. 2.100  +30 (+1.45%)


Loading...
DVLA Rp. 2.100  +30 (+1.45%)
Last Update 24 June 2017 04:00 PM
Open
Rp. 2,070
Prev Close
Rp. 2,070
Offer
Rp. 2,100
Bid
Rp. 2,070
Day Low
Rp. 2,070
Day High
Rp. 2,100
Volume
296 Lots (29,600 Shares)
Value
62.06 M
Frequency
7
EPS
-6.22
PE Ratio (ttm)
-337.75
Market Cap.
2,352,000.00 M
Market Cap. Rank in Industry
#7 of 11 Companies in Pharmaceuticals
Market Cap. Rank in All Companies
#239 of 568 Companies
F
Net Foreign

This section of IDNFinancials requires you to sign up as a premium member of IDNFinancials.

Please check our pricing page to see all of our features.
O
Overview


PT Darya-Varia Laboratoria Tbk (DVLA) is engaged in the manufacture and trade of pharmaceutical products and cosmetics. The Company started commercial operations in 1976. The Company, through its parent entity, Blue Sphere Singapore Pte Ltd, is an affiliate of United Laboratories Inc, a pharmaceutical company based in the Philippines.

 

Source: www.darya-varia.com

Subsidiary Affiliation
 
Company
Percentage
1.
PT. Pabrik Obat Dupa
99.9 %
G
Management
Commissioners
-
President Commissioner
Vice President Commissioner
Commissioner
Independent Commissioner
Darodjatun Sanusi
Independent Commissioner
Independent Commissioner
Directors
-
President Director
Vice President Director
Director
Alex Espenilla Manlapas
Director
Roen Libarnes De Leon
Independent Director
Graph goes here...
S
Shareholders
No. Shareholder Name Number of Shares Total Paidup Capital Percentage
1. Blue Sphere Singapore Pte Ltd 1,031,800,912 257,950,228,000 (IDR) 92.46 %
2. Public (each below 5%) 84,124,388 21,031,097,000 (IDR) 7.54 %
3. Treasury stock 4,074,700 1,018,675,000 (IDR) -
V
Videos
IDNFinancials Video - Darya expects increased performance by 2016
26 May 2016 03:48 PM
JAKARTA - PT Darya Varia Laboratoria Tbk (DVLA) expects the purchasing power of consumers in Indonesia to increase, which will impact the company’s revenue in 2016...
IDNFinancials Video - Darya claims 10% prescription increase but financial statement suggests otherwise
26 May 2016 03:42 PM
JAKARTA – PT Darya Varia Laboratoria Tbk (DVLA) claimed they noted prescription products sales increase in the first quarter 2016 compared with the same period in 2016...
A
Announcement
Darya Varia Laboratoria distributes cash dividend Rp 65 per share Cum June 8, 2017
2017-06-06 13:15:25
Links: [1]
Darya-Varia Laboratoria pays dividend Rp35 per share cum June 1, 2016
2016-05-26 23:50:41
Links: [1]
Darya-Varia Laboratoria will hold annual shareholders' meeting on May 25, 2016
2016-04-18 23:30:37
Links: [1] [2]
Darya-Varia Laboratoria pays dividend Rp. 30 per share cum September 14, 2015
2015-09-08 23:30:22
Links: [1] [2] [3]
S
Financial
Period Revenue Net Profit
Q4 - 2016 299,994 M 14,693 M
Q3 - 2016 386,997 M 53,984 M
Q2 - 2016 385,053 M 26,828 M
Q1 - 2016 379,312 M 56,578 M
Q4 - 2015 321,164 M 10,142 M
Q3 - 2015 314,281 M 20,444 M
Q2 - 2015 328,296 M 17,468 M
Q1 - 2015 342,357 M 59,840 M
Full financial and operational data available to our premium users. Please check our premium data introduction page to learn more about our tools.
29 October 2014 04:33 PM
16 September 2014 10:46 AM
27 March 2014 05:27 PM
30 October 2013 03:36 PM
01 August 2013 03:24 PM
21 March 2013 11:16 AM
20 February 2013 03:44 PM
30 November 2012 02:05 PM
30 November 2012 02:04 PM